Skip to main content
European Commission logo
IP Helpdesk
Training and workshops

Nordic Health Virtual Market Entry Programme Singapore 2021

» Download the webinar PPT
» Watch the webinar recording

 

This year, the Nordic Innovation House Singapore (NIH-SG) theme on Health aims to support and provide Nordic Health companies with an opportunity to expand their foothold in Singapore and Southeast Asia. The three-phase programme involves partnering with Singapore and Southeast Asia key partners managing and seeking solutions in the public and private healthcare sector. 

Nordic countries and Singapore share a lot of similar challenges in healthcare, such as the rapidly aging population, a limited number of hospital beds, increased burden on managing complex chronic diseases and the need for better patient experience. A more integrated care system focused on the primary care and community is key for future health and health care transformation.

This programme aims to connect the selected Nordic Health companies to address multiple problem statement areas through our partners introduction webinars, showcasing opportunities, and tailored 1-to-1 business matchmaking sessions. Furthermore, adopting and unifying #nordicmade digital solutions to transform the healthcare industry. 

Nordic Health Virtual Market Entry Programme 2021 is organised by NIH-SG and Nordic partners at the Embassy of Finland in Singapore, Embassy of Denmark in Singapore, Business Sweden, Innovation Norway, and Business Iceland.

On 14 September 2021, Mr. James Kinnaird - External Expert of South-East Asia IP SME Helpdesk and Partner of Marks & Clerk Singapore LLP, will attend and deliver an IP Presentation focusing on  “Intellectual Property Protection in the Healthcare Sector in Singapore” from 7.30 - 8.30 (CEST)/ 13.30 - 14.30 (Singapore Time).

*By Invitation Only

  • intellectual property | health care industry
  • -
  • Live streaming available

Practical information

When
-
Languages
English
Organisers
Nordic Innovation House Singapore (NIH-SG)